Amber Ophthalmics
San Diego, United States· Est. 2016
Amber Ophthalmics develops sustained-release drug delivery technologies for treating ophthalmic diseases.
Private Company
Total funding raised: $23M
About
Amber Ophthalmics develops sustained-release drug delivery technologies for treating ophthalmic diseases.
Small Molecules
Funding History
2Total raised:$23M
Series A$20MAug 15, 2022
Seed$3MNov 15, 2020